Global Needle Free Injectors Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Needle Free Injectors market size is predicted to grow from US$ 216 million in 2025 to US$ 266 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031.
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Firstly, the technology of needle-free injection device industry is developing and the industry concentration is not high, There are over 30 manufacturers around the world, and the leading companies are Zogenix, Bioject, Glide Pharma, Crossject Medical and Injex Pharma, right now the production is almost dominated by producers in Europe and United States. In United States, a few companies occupy more than 60 percent of domestic needle-free injector market. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India. USA and Europe have a long history and unshakable status in this industry, such as Bioject and Akra Dermojet, leading the needle-free injection device industry. As to Japan, many big corporation has come into this area, however, the rate of the business in this area is not high compared to other area because Japanese companies always have many business areas. In Germany, it is Injex Pharma that lead the industry.
LP Information, Inc. (LPI) ' newest research report, the “Needle Free Injectors Industry Forecast” looks at past sales and reviews total world Needle Free Injectors sales in 2024, providing a comprehensive analysis by region and market sector of projected Needle Free Injectors sales for 2025 through 2031. With Needle Free Injectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Needle Free Injectors industry.
This Insight Report provides a comprehensive analysis of the global Needle Free Injectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Needle Free Injectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Needle Free Injectors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Needle Free Injectors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Needle Free Injectors.
This report presents a comprehensive overview, market shares, and growth opportunities of Needle Free Injectors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Needle Free Injectors market?
What factors are driving Needle Free Injectors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Needle Free Injectors market opportunities vary by end market size?
How does Needle Free Injectors break out by Type, by Application?
The global Needle Free Injectors market size is predicted to grow from US$ 216 million in 2025 to US$ 266 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031.
Needle-free Injection Device is a type of medical injecting syringe that uses a high-pressure narrow jet of the injection liquid instead of a hypodermic needle to penetrate the epidermis. It is powered by compressed air or gas, either by a pressure hose from a large cylinder, or form a built-in gas cartridge, small cylinder, or spring.
Needle-free injection systems are novel ways to introduce various medicines into patients without piercing the skin with a conventional needle. It was developed to reduce the number of needle stick accidents and associated problems.
Firstly, the technology of needle-free injection device industry is developing and the industry concentration is not high, There are over 30 manufacturers around the world, and the leading companies are Zogenix, Bioject, Glide Pharma, Crossject Medical and Injex Pharma, right now the production is almost dominated by producers in Europe and United States. In United States, a few companies occupy more than 60 percent of domestic needle-free injector market. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India. USA and Europe have a long history and unshakable status in this industry, such as Bioject and Akra Dermojet, leading the needle-free injection device industry. As to Japan, many big corporation has come into this area, however, the rate of the business in this area is not high compared to other area because Japanese companies always have many business areas. In Germany, it is Injex Pharma that lead the industry.
LP Information, Inc. (LPI) ' newest research report, the “Needle Free Injectors Industry Forecast” looks at past sales and reviews total world Needle Free Injectors sales in 2024, providing a comprehensive analysis by region and market sector of projected Needle Free Injectors sales for 2025 through 2031. With Needle Free Injectors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Needle Free Injectors industry.
This Insight Report provides a comprehensive analysis of the global Needle Free Injectors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Needle Free Injectors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Needle Free Injectors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Needle Free Injectors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Needle Free Injectors.
This report presents a comprehensive overview, market shares, and growth opportunities of Needle Free Injectors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Fillable
- Prefilled
- Hospitals
- Clinics
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- PharmaJet
- Medical International Technology
- National Medical Products
- European Pharma Group
- Valeritas
- Endo International
- Injex Pharma GmbH
- Bioject Medical Technologies
- Antares Pharma
- European Pharma Group
- Wuhan ZJKC Technology
- PenJet Corporation
What is the 10-year outlook for the global Needle Free Injectors market?
What factors are driving Needle Free Injectors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Needle Free Injectors market opportunities vary by end market size?
How does Needle Free Injectors break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Needle Free Injectors Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Needle Free Injectors by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Needle Free Injectors by Country/Region, 2020, 2024 & 2031
2.2 Needle Free Injectors Segment by Type
2.2.1 Fillable
2.2.2 Prefilled
2.3 Needle Free Injectors Sales by Type
2.3.1 Global Needle Free Injectors Sales Market Share by Type (2020-2025)
2.3.2 Global Needle Free Injectors Revenue and Market Share by Type (2020-2025)
2.3.3 Global Needle Free Injectors Sale Price by Type (2020-2025)
2.4 Needle Free Injectors Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Needle Free Injectors Sales by Application
2.5.1 Global Needle Free Injectors Sale Market Share by Application (2020-2025)
2.5.2 Global Needle Free Injectors Revenue and Market Share by Application (2020-2025)
2.5.3 Global Needle Free Injectors Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Needle Free Injectors Breakdown Data by Company
3.1.1 Global Needle Free Injectors Annual Sales by Company (2020-2025)
3.1.2 Global Needle Free Injectors Sales Market Share by Company (2020-2025)
3.2 Global Needle Free Injectors Annual Revenue by Company (2020-2025)
3.2.1 Global Needle Free Injectors Revenue by Company (2020-2025)
3.2.2 Global Needle Free Injectors Revenue Market Share by Company (2020-2025)
3.3 Global Needle Free Injectors Sale Price by Company
3.4 Key Manufacturers Needle Free Injectors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Needle Free Injectors Product Location Distribution
3.4.2 Players Needle Free Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEEDLE FREE INJECTORS BY GEOGRAPHIC REGION
4.1 World Historic Needle Free Injectors Market Size by Geographic Region (2020-2025)
4.1.1 Global Needle Free Injectors Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Needle Free Injectors Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Needle Free Injectors Market Size by Country/Region (2020-2025)
4.2.1 Global Needle Free Injectors Annual Sales by Country/Region (2020-2025)
4.2.2 Global Needle Free Injectors Annual Revenue by Country/Region (2020-2025)
4.3 Americas Needle Free Injectors Sales Growth
4.4 APAC Needle Free Injectors Sales Growth
4.5 Europe Needle Free Injectors Sales Growth
4.6 Middle East & Africa Needle Free Injectors Sales Growth
5 AMERICAS
5.1 Americas Needle Free Injectors Sales by Country
5.1.1 Americas Needle Free Injectors Sales by Country (2020-2025)
5.1.2 Americas Needle Free Injectors Revenue by Country (2020-2025)
5.2 Americas Needle Free Injectors Sales by Type (2020-2025)
5.3 Americas Needle Free Injectors Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Needle Free Injectors Sales by Region
6.1.1 APAC Needle Free Injectors Sales by Region (2020-2025)
6.1.2 APAC Needle Free Injectors Revenue by Region (2020-2025)
6.2 APAC Needle Free Injectors Sales by Type (2020-2025)
6.3 APAC Needle Free Injectors Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Needle Free Injectors by Country
7.1.1 Europe Needle Free Injectors Sales by Country (2020-2025)
7.1.2 Europe Needle Free Injectors Revenue by Country (2020-2025)
7.2 Europe Needle Free Injectors Sales by Type (2020-2025)
7.3 Europe Needle Free Injectors Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Needle Free Injectors by Country
8.1.1 Middle East & Africa Needle Free Injectors Sales by Country (2020-2025)
8.1.2 Middle East & Africa Needle Free Injectors Revenue by Country (2020-2025)
8.2 Middle East & Africa Needle Free Injectors Sales by Type (2020-2025)
8.3 Middle East & Africa Needle Free Injectors Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Needle Free Injectors
10.3 Manufacturing Process Analysis of Needle Free Injectors
10.4 Industry Chain Structure of Needle Free Injectors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Needle Free Injectors Distributors
11.3 Needle Free Injectors Customer
12 WORLD FORECAST REVIEW FOR NEEDLE FREE INJECTORS BY GEOGRAPHIC REGION
12.1 Global Needle Free Injectors Market Size Forecast by Region
12.1.1 Global Needle Free Injectors Forecast by Region (2026-2031)
12.1.2 Global Needle Free Injectors Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Needle Free Injectors Forecast by Type (2026-2031)
12.7 Global Needle Free Injectors Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 PharmaJet
13.1.1 PharmaJet Company Information
13.1.2 PharmaJet Needle Free Injectors Product Portfolios and Specifications
13.1.3 PharmaJet Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 PharmaJet Main Business Overview
13.1.5 PharmaJet Latest Developments
13.2 Medical International Technology
13.2.1 Medical International Technology Company Information
13.2.2 Medical International Technology Needle Free Injectors Product Portfolios and Specifications
13.2.3 Medical International Technology Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Medical International Technology Main Business Overview
13.2.5 Medical International Technology Latest Developments
13.3 National Medical Products
13.3.1 National Medical Products Company Information
13.3.2 National Medical Products Needle Free Injectors Product Portfolios and Specifications
13.3.3 National Medical Products Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 National Medical Products Main Business Overview
13.3.5 National Medical Products Latest Developments
13.4 European Pharma Group
13.4.1 European Pharma Group Company Information
13.4.2 European Pharma Group Needle Free Injectors Product Portfolios and Specifications
13.4.3 European Pharma Group Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 European Pharma Group Main Business Overview
13.4.5 European Pharma Group Latest Developments
13.5 Valeritas
13.5.1 Valeritas Company Information
13.5.2 Valeritas Needle Free Injectors Product Portfolios and Specifications
13.5.3 Valeritas Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Valeritas Main Business Overview
13.5.5 Valeritas Latest Developments
13.6 Endo International
13.6.1 Endo International Company Information
13.6.2 Endo International Needle Free Injectors Product Portfolios and Specifications
13.6.3 Endo International Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Endo International Main Business Overview
13.6.5 Endo International Latest Developments
13.7 Injex Pharma GmbH
13.7.1 Injex Pharma GmbH Company Information
13.7.2 Injex Pharma GmbH Needle Free Injectors Product Portfolios and Specifications
13.7.3 Injex Pharma GmbH Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Injex Pharma GmbH Main Business Overview
13.7.5 Injex Pharma GmbH Latest Developments
13.8 Bioject Medical Technologies
13.8.1 Bioject Medical Technologies Company Information
13.8.2 Bioject Medical Technologies Needle Free Injectors Product Portfolios and Specifications
13.8.3 Bioject Medical Technologies Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bioject Medical Technologies Main Business Overview
13.8.5 Bioject Medical Technologies Latest Developments
13.9 Antares Pharma
13.9.1 Antares Pharma Company Information
13.9.2 Antares Pharma Needle Free Injectors Product Portfolios and Specifications
13.9.3 Antares Pharma Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Antares Pharma Main Business Overview
13.9.5 Antares Pharma Latest Developments
13.10 European Pharma Group
13.10.1 European Pharma Group Company Information
13.10.2 European Pharma Group Needle Free Injectors Product Portfolios and Specifications
13.10.3 European Pharma Group Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 European Pharma Group Main Business Overview
13.10.5 European Pharma Group Latest Developments
13.11 Wuhan ZJKC Technology
13.11.1 Wuhan ZJKC Technology Company Information
13.11.2 Wuhan ZJKC Technology Needle Free Injectors Product Portfolios and Specifications
13.11.3 Wuhan ZJKC Technology Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Wuhan ZJKC Technology Main Business Overview
13.11.5 Wuhan ZJKC Technology Latest Developments
13.12 PenJet Corporation
13.12.1 PenJet Corporation Company Information
13.12.2 PenJet Corporation Needle Free Injectors Product Portfolios and Specifications
13.12.3 PenJet Corporation Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 PenJet Corporation Main Business Overview
13.12.5 PenJet Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. NeedleFree Injectors Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. NeedleFree Injectors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofFillable
Table 4. Major Players of Prefilled
Table 5. Global NeedleFree Injectors Sales byType (2020-2025) & (K Units)
Table 6. Global NeedleFree Injectors Sales Market Share byType (2020-2025)
Table 7. Global NeedleFree Injectors Revenue byType (2020-2025) & ($ million)
Table 8. Global NeedleFree Injectors Revenue Market Share byType (2020-2025)
Table 9. Global NeedleFree Injectors Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global NeedleFree Injectors Sale by Application (2020-2025) & (K Units)
Table 11. Global NeedleFree Injectors Sale Market Share by Application (2020-2025)
Table 12. Global NeedleFree Injectors Revenue by Application (2020-2025) & ($ million)
Table 13. Global NeedleFree Injectors Revenue Market Share by Application (2020-2025)
Table 14. Global NeedleFree Injectors Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global NeedleFree Injectors Sales by Company (2020-2025) & (K Units)
Table 16. Global NeedleFree Injectors Sales Market Share by Company (2020-2025)
Table 17. Global NeedleFree Injectors Revenue by Company (2020-2025) & ($ millions)
Table 18. Global NeedleFree Injectors Revenue Market Share by Company (2020-2025)
Table 19. Global NeedleFree Injectors Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers NeedleFree Injectors Producing Area Distribution and Sales Area
Table 21. Players NeedleFree Injectors Products Offered
Table 22. NeedleFree Injectors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global NeedleFree Injectors Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global NeedleFree Injectors Sales Market Share Geographic Region (2020-2025)
Table 27. Global NeedleFree Injectors Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global NeedleFree Injectors Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global NeedleFree Injectors Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global NeedleFree Injectors Sales Market Share by Country/Region (2020-2025)
Table 31. Global NeedleFree Injectors Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global NeedleFree Injectors Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas NeedleFree Injectors Sales by Country (2020-2025) & (K Units)
Table 34. Americas NeedleFree Injectors Sales Market Share by Country (2020-2025)
Table 35. Americas NeedleFree Injectors Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas NeedleFree Injectors Sales byType (2020-2025) & (K Units)
Table 37. Americas NeedleFree Injectors Sales by Application (2020-2025) & (K Units)
Table 38. APAC NeedleFree Injectors Sales by Region (2020-2025) & (K Units)
Table 39. APAC NeedleFree Injectors Sales Market Share by Region (2020-2025)
Table 40. APAC NeedleFree Injectors Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC NeedleFree Injectors Sales byType (2020-2025) & (K Units)
Table 42. APAC NeedleFree Injectors Sales by Application (2020-2025) & (K Units)
Table 43. Europe NeedleFree Injectors Sales by Country (2020-2025) & (K Units)
Table 44. Europe NeedleFree Injectors Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe NeedleFree Injectors Sales byType (2020-2025) & (K Units)
Table 46. Europe NeedleFree Injectors Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa NeedleFree Injectors Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa NeedleFree Injectors Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa NeedleFree Injectors Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa NeedleFree Injectors Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of NeedleFree Injectors
Table 52. Key Market Challenges & Risks of NeedleFree Injectors
Table 53. Key IndustryTrends of NeedleFree Injectors
Table 54. NeedleFree Injectors Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. NeedleFree Injectors Distributors List
Table 57. NeedleFree Injectors Customer List
Table 58. Global NeedleFree Injectors SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global NeedleFree Injectors RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas NeedleFree Injectors SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas NeedleFree Injectors Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC NeedleFree Injectors SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC NeedleFree Injectors Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe NeedleFree Injectors SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe NeedleFree Injectors RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa NeedleFree Injectors SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa NeedleFree Injectors RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global NeedleFree Injectors SalesForecast byType (2026-2031) & (K Units)
Table 69. Global NeedleFree Injectors RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global NeedleFree Injectors SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global NeedleFree Injectors RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. PharmaJet Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 73. PharmaJet NeedleFree Injectors Product Portfolios and Specifications
Table 74. PharmaJet NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. PharmaJet Main Business
Table 76. PharmaJet Latest Developments
Table 77. Medical InternationalTechnology Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 78. Medical InternationalTechnology NeedleFree Injectors Product Portfolios and Specifications
Table 79. Medical InternationalTechnology NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Medical InternationalTechnology Main Business
Table 81. Medical InternationalTechnology Latest Developments
Table 82. National Medical Products Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 83. National Medical Products NeedleFree Injectors Product Portfolios and Specifications
Table 84. National Medical Products NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. National Medical Products Main Business
Table 86. National Medical Products Latest Developments
Table 87. European Pharma Group Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 88. European Pharma Group NeedleFree Injectors Product Portfolios and Specifications
Table 89. European Pharma Group NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. European Pharma Group Main Business
Table 91. European Pharma Group Latest Developments
Table 92. Valeritas Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 93. Valeritas NeedleFree Injectors Product Portfolios and Specifications
Table 94. Valeritas NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Valeritas Main Business
Table 96. Valeritas Latest Developments
Table 97. Endo International Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 98. Endo International NeedleFree Injectors Product Portfolios and Specifications
Table 99. Endo International NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Endo International Main Business
Table 101. Endo International Latest Developments
Table 102. Injex Pharma GmbH Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 103. Injex Pharma GmbH NeedleFree Injectors Product Portfolios and Specifications
Table 104. Injex Pharma GmbH NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Injex Pharma GmbH Main Business
Table 106. Injex Pharma GmbH Latest Developments
Table 107. Bioject MedicalTechnologies Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 108. Bioject MedicalTechnologies NeedleFree Injectors Product Portfolios and Specifications
Table 109. Bioject MedicalTechnologies NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Bioject MedicalTechnologies Main Business
Table 111. Bioject MedicalTechnologies Latest Developments
Table 112. Antares Pharma Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 113. Antares Pharma NeedleFree Injectors Product Portfolios and Specifications
Table 114. Antares Pharma NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Antares Pharma Main Business
Table 116. Antares Pharma Latest Developments
Table 117. European Pharma Group Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 118. European Pharma Group NeedleFree Injectors Product Portfolios and Specifications
Table 119. European Pharma Group NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. European Pharma Group Main Business
Table 121. European Pharma Group Latest Developments
Table 122. Wuhan ZJKCTechnology Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 123. Wuhan ZJKCTechnology NeedleFree Injectors Product Portfolios and Specifications
Table 124. Wuhan ZJKCTechnology NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Wuhan ZJKCTechnology Main Business
Table 126. Wuhan ZJKCTechnology Latest Developments
Table 127. PenJet Corporation Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 128. PenJet Corporation NeedleFree Injectors Product Portfolios and Specifications
Table 129. PenJet Corporation NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. PenJet Corporation Main Business
Table 131. PenJet Corporation Latest Developments
LIST OFFIGURES
Figure 1. Picture of NeedleFree Injectors
Figure 2. NeedleFree Injectors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NeedleFree Injectors Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global NeedleFree Injectors Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. NeedleFree Injectors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. NeedleFree Injectors Sales Market Share by Country/Region (2024)
Figure 10. NeedleFree Injectors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofFillable
Figure 12. Product Picture of Prefilled
Figure 13. Global NeedleFree Injectors Sales Market Share byType in 2025
Figure 14. Global NeedleFree Injectors Revenue Market Share byType (2020-2025)
Figure 15. NeedleFree Injectors Consumed in Hospitals
Figure 16. Global NeedleFree Injectors Market: Hospitals (2020-2025) & (K Units)
Figure 17. NeedleFree Injectors Consumed in Clinics
Figure 18. Global NeedleFree Injectors Market: Clinics (2020-2025) & (K Units)
Figure 19. NeedleFree Injectors Consumed in Other
Figure 20. Global NeedleFree Injectors Market: Other (2020-2025) & (K Units)
Figure 21. Global NeedleFree Injectors Sale Market Share by Application (2024)
Figure 22. Global NeedleFree Injectors Revenue Market Share by Application in 2025
Figure 23. NeedleFree Injectors Sales by Company in 2025 (K Units)
Figure 24. Global NeedleFree Injectors Sales Market Share by Company in 2025
Figure 25. NeedleFree Injectors Revenue by Company in 2025 ($ millions)
Figure 26. Global NeedleFree Injectors Revenue Market Share by Company in 2025
Figure 27. Global NeedleFree Injectors Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global NeedleFree Injectors Revenue Market Share by Geographic Region in 2025
Figure 29. Americas NeedleFree Injectors Sales 2020-2025 (K Units)
Figure 30. Americas NeedleFree Injectors Revenue 2020-2025 ($ millions)
Figure 31. APAC NeedleFree Injectors Sales 2020-2025 (K Units)
Figure 32. APAC NeedleFree Injectors Revenue 2020-2025 ($ millions)
Figure 33. Europe NeedleFree Injectors Sales 2020-2025 (K Units)
Figure 34. Europe NeedleFree Injectors Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa NeedleFree Injectors Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa NeedleFree Injectors Revenue 2020-2025 ($ millions)
Figure 37. Americas NeedleFree Injectors Sales Market Share by Country in 2025
Figure 38. Americas NeedleFree Injectors Revenue Market Share by Country (2020-2025)
Figure 39. Americas NeedleFree Injectors Sales Market Share byType (2020-2025)
Figure 40. Americas NeedleFree Injectors Sales Market Share by Application (2020-2025)
Figure 41. United States NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC NeedleFree Injectors Sales Market Share by Region in 2025
Figure 46. APAC NeedleFree Injectors Revenue Market Share by Region (2020-2025)
Figure 47. APAC NeedleFree Injectors Sales Market Share byType (2020-2025)
Figure 48. APAC NeedleFree Injectors Sales Market Share by Application (2020-2025)
Figure 49. China NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 53. India NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe NeedleFree Injectors Sales Market Share by Country in 2025
Figure 57. Europe NeedleFree Injectors Revenue Market Share by Country (2020-2025)
Figure 58. Europe NeedleFree Injectors Sales Market Share byType (2020-2025)
Figure 59. Europe NeedleFree Injectors Sales Market Share by Application (2020-2025)
Figure 60. Germany NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 61.France NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 62. UK NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa NeedleFree Injectors Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa NeedleFree Injectors Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa NeedleFree Injectors Sales Market Share by Application (2020-2025)
Figure 68. Egypt NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of NeedleFree Injectors in 2025
Figure 74. Manufacturing Process Analysis of NeedleFree Injectors
Figure 75. Industry Chain Structure of NeedleFree Injectors
Figure 76. Channels of Distribution
Figure 77. Global NeedleFree Injectors Sales MarketForecast by Region (2026-2031)
Figure 78. Global NeedleFree Injectors Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global NeedleFree Injectors Sales Market ShareForecast byType (2026-2031)
Figure 80. Global NeedleFree Injectors Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global NeedleFree Injectors Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global NeedleFree Injectors Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Needle Free Injectors Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Needle Free Injectors by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Needle Free Injectors by Country/Region, 2020, 2024 & 2031
2.2 Needle Free Injectors Segment by Type
2.2.1 Fillable
2.2.2 Prefilled
2.3 Needle Free Injectors Sales by Type
2.3.1 Global Needle Free Injectors Sales Market Share by Type (2020-2025)
2.3.2 Global Needle Free Injectors Revenue and Market Share by Type (2020-2025)
2.3.3 Global Needle Free Injectors Sale Price by Type (2020-2025)
2.4 Needle Free Injectors Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Needle Free Injectors Sales by Application
2.5.1 Global Needle Free Injectors Sale Market Share by Application (2020-2025)
2.5.2 Global Needle Free Injectors Revenue and Market Share by Application (2020-2025)
2.5.3 Global Needle Free Injectors Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Needle Free Injectors Breakdown Data by Company
3.1.1 Global Needle Free Injectors Annual Sales by Company (2020-2025)
3.1.2 Global Needle Free Injectors Sales Market Share by Company (2020-2025)
3.2 Global Needle Free Injectors Annual Revenue by Company (2020-2025)
3.2.1 Global Needle Free Injectors Revenue by Company (2020-2025)
3.2.2 Global Needle Free Injectors Revenue Market Share by Company (2020-2025)
3.3 Global Needle Free Injectors Sale Price by Company
3.4 Key Manufacturers Needle Free Injectors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Needle Free Injectors Product Location Distribution
3.4.2 Players Needle Free Injectors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEEDLE FREE INJECTORS BY GEOGRAPHIC REGION
4.1 World Historic Needle Free Injectors Market Size by Geographic Region (2020-2025)
4.1.1 Global Needle Free Injectors Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Needle Free Injectors Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Needle Free Injectors Market Size by Country/Region (2020-2025)
4.2.1 Global Needle Free Injectors Annual Sales by Country/Region (2020-2025)
4.2.2 Global Needle Free Injectors Annual Revenue by Country/Region (2020-2025)
4.3 Americas Needle Free Injectors Sales Growth
4.4 APAC Needle Free Injectors Sales Growth
4.5 Europe Needle Free Injectors Sales Growth
4.6 Middle East & Africa Needle Free Injectors Sales Growth
5 AMERICAS
5.1 Americas Needle Free Injectors Sales by Country
5.1.1 Americas Needle Free Injectors Sales by Country (2020-2025)
5.1.2 Americas Needle Free Injectors Revenue by Country (2020-2025)
5.2 Americas Needle Free Injectors Sales by Type (2020-2025)
5.3 Americas Needle Free Injectors Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Needle Free Injectors Sales by Region
6.1.1 APAC Needle Free Injectors Sales by Region (2020-2025)
6.1.2 APAC Needle Free Injectors Revenue by Region (2020-2025)
6.2 APAC Needle Free Injectors Sales by Type (2020-2025)
6.3 APAC Needle Free Injectors Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Needle Free Injectors by Country
7.1.1 Europe Needle Free Injectors Sales by Country (2020-2025)
7.1.2 Europe Needle Free Injectors Revenue by Country (2020-2025)
7.2 Europe Needle Free Injectors Sales by Type (2020-2025)
7.3 Europe Needle Free Injectors Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Needle Free Injectors by Country
8.1.1 Middle East & Africa Needle Free Injectors Sales by Country (2020-2025)
8.1.2 Middle East & Africa Needle Free Injectors Revenue by Country (2020-2025)
8.2 Middle East & Africa Needle Free Injectors Sales by Type (2020-2025)
8.3 Middle East & Africa Needle Free Injectors Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Needle Free Injectors
10.3 Manufacturing Process Analysis of Needle Free Injectors
10.4 Industry Chain Structure of Needle Free Injectors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Needle Free Injectors Distributors
11.3 Needle Free Injectors Customer
12 WORLD FORECAST REVIEW FOR NEEDLE FREE INJECTORS BY GEOGRAPHIC REGION
12.1 Global Needle Free Injectors Market Size Forecast by Region
12.1.1 Global Needle Free Injectors Forecast by Region (2026-2031)
12.1.2 Global Needle Free Injectors Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Needle Free Injectors Forecast by Type (2026-2031)
12.7 Global Needle Free Injectors Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 PharmaJet
13.1.1 PharmaJet Company Information
13.1.2 PharmaJet Needle Free Injectors Product Portfolios and Specifications
13.1.3 PharmaJet Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 PharmaJet Main Business Overview
13.1.5 PharmaJet Latest Developments
13.2 Medical International Technology
13.2.1 Medical International Technology Company Information
13.2.2 Medical International Technology Needle Free Injectors Product Portfolios and Specifications
13.2.3 Medical International Technology Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Medical International Technology Main Business Overview
13.2.5 Medical International Technology Latest Developments
13.3 National Medical Products
13.3.1 National Medical Products Company Information
13.3.2 National Medical Products Needle Free Injectors Product Portfolios and Specifications
13.3.3 National Medical Products Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 National Medical Products Main Business Overview
13.3.5 National Medical Products Latest Developments
13.4 European Pharma Group
13.4.1 European Pharma Group Company Information
13.4.2 European Pharma Group Needle Free Injectors Product Portfolios and Specifications
13.4.3 European Pharma Group Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 European Pharma Group Main Business Overview
13.4.5 European Pharma Group Latest Developments
13.5 Valeritas
13.5.1 Valeritas Company Information
13.5.2 Valeritas Needle Free Injectors Product Portfolios and Specifications
13.5.3 Valeritas Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Valeritas Main Business Overview
13.5.5 Valeritas Latest Developments
13.6 Endo International
13.6.1 Endo International Company Information
13.6.2 Endo International Needle Free Injectors Product Portfolios and Specifications
13.6.3 Endo International Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Endo International Main Business Overview
13.6.5 Endo International Latest Developments
13.7 Injex Pharma GmbH
13.7.1 Injex Pharma GmbH Company Information
13.7.2 Injex Pharma GmbH Needle Free Injectors Product Portfolios and Specifications
13.7.3 Injex Pharma GmbH Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Injex Pharma GmbH Main Business Overview
13.7.5 Injex Pharma GmbH Latest Developments
13.8 Bioject Medical Technologies
13.8.1 Bioject Medical Technologies Company Information
13.8.2 Bioject Medical Technologies Needle Free Injectors Product Portfolios and Specifications
13.8.3 Bioject Medical Technologies Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Bioject Medical Technologies Main Business Overview
13.8.5 Bioject Medical Technologies Latest Developments
13.9 Antares Pharma
13.9.1 Antares Pharma Company Information
13.9.2 Antares Pharma Needle Free Injectors Product Portfolios and Specifications
13.9.3 Antares Pharma Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Antares Pharma Main Business Overview
13.9.5 Antares Pharma Latest Developments
13.10 European Pharma Group
13.10.1 European Pharma Group Company Information
13.10.2 European Pharma Group Needle Free Injectors Product Portfolios and Specifications
13.10.3 European Pharma Group Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 European Pharma Group Main Business Overview
13.10.5 European Pharma Group Latest Developments
13.11 Wuhan ZJKC Technology
13.11.1 Wuhan ZJKC Technology Company Information
13.11.2 Wuhan ZJKC Technology Needle Free Injectors Product Portfolios and Specifications
13.11.3 Wuhan ZJKC Technology Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Wuhan ZJKC Technology Main Business Overview
13.11.5 Wuhan ZJKC Technology Latest Developments
13.12 PenJet Corporation
13.12.1 PenJet Corporation Company Information
13.12.2 PenJet Corporation Needle Free Injectors Product Portfolios and Specifications
13.12.3 PenJet Corporation Needle Free Injectors Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 PenJet Corporation Main Business Overview
13.12.5 PenJet Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. NeedleFree Injectors Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. NeedleFree Injectors Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofFillable
Table 4. Major Players of Prefilled
Table 5. Global NeedleFree Injectors Sales byType (2020-2025) & (K Units)
Table 6. Global NeedleFree Injectors Sales Market Share byType (2020-2025)
Table 7. Global NeedleFree Injectors Revenue byType (2020-2025) & ($ million)
Table 8. Global NeedleFree Injectors Revenue Market Share byType (2020-2025)
Table 9. Global NeedleFree Injectors Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global NeedleFree Injectors Sale by Application (2020-2025) & (K Units)
Table 11. Global NeedleFree Injectors Sale Market Share by Application (2020-2025)
Table 12. Global NeedleFree Injectors Revenue by Application (2020-2025) & ($ million)
Table 13. Global NeedleFree Injectors Revenue Market Share by Application (2020-2025)
Table 14. Global NeedleFree Injectors Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global NeedleFree Injectors Sales by Company (2020-2025) & (K Units)
Table 16. Global NeedleFree Injectors Sales Market Share by Company (2020-2025)
Table 17. Global NeedleFree Injectors Revenue by Company (2020-2025) & ($ millions)
Table 18. Global NeedleFree Injectors Revenue Market Share by Company (2020-2025)
Table 19. Global NeedleFree Injectors Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers NeedleFree Injectors Producing Area Distribution and Sales Area
Table 21. Players NeedleFree Injectors Products Offered
Table 22. NeedleFree Injectors Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global NeedleFree Injectors Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global NeedleFree Injectors Sales Market Share Geographic Region (2020-2025)
Table 27. Global NeedleFree Injectors Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global NeedleFree Injectors Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global NeedleFree Injectors Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global NeedleFree Injectors Sales Market Share by Country/Region (2020-2025)
Table 31. Global NeedleFree Injectors Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global NeedleFree Injectors Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas NeedleFree Injectors Sales by Country (2020-2025) & (K Units)
Table 34. Americas NeedleFree Injectors Sales Market Share by Country (2020-2025)
Table 35. Americas NeedleFree Injectors Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas NeedleFree Injectors Sales byType (2020-2025) & (K Units)
Table 37. Americas NeedleFree Injectors Sales by Application (2020-2025) & (K Units)
Table 38. APAC NeedleFree Injectors Sales by Region (2020-2025) & (K Units)
Table 39. APAC NeedleFree Injectors Sales Market Share by Region (2020-2025)
Table 40. APAC NeedleFree Injectors Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC NeedleFree Injectors Sales byType (2020-2025) & (K Units)
Table 42. APAC NeedleFree Injectors Sales by Application (2020-2025) & (K Units)
Table 43. Europe NeedleFree Injectors Sales by Country (2020-2025) & (K Units)
Table 44. Europe NeedleFree Injectors Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe NeedleFree Injectors Sales byType (2020-2025) & (K Units)
Table 46. Europe NeedleFree Injectors Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa NeedleFree Injectors Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa NeedleFree Injectors Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa NeedleFree Injectors Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa NeedleFree Injectors Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of NeedleFree Injectors
Table 52. Key Market Challenges & Risks of NeedleFree Injectors
Table 53. Key IndustryTrends of NeedleFree Injectors
Table 54. NeedleFree Injectors Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. NeedleFree Injectors Distributors List
Table 57. NeedleFree Injectors Customer List
Table 58. Global NeedleFree Injectors SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global NeedleFree Injectors RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas NeedleFree Injectors SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas NeedleFree Injectors Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC NeedleFree Injectors SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC NeedleFree Injectors Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe NeedleFree Injectors SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe NeedleFree Injectors RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa NeedleFree Injectors SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa NeedleFree Injectors RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global NeedleFree Injectors SalesForecast byType (2026-2031) & (K Units)
Table 69. Global NeedleFree Injectors RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global NeedleFree Injectors SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global NeedleFree Injectors RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. PharmaJet Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 73. PharmaJet NeedleFree Injectors Product Portfolios and Specifications
Table 74. PharmaJet NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. PharmaJet Main Business
Table 76. PharmaJet Latest Developments
Table 77. Medical InternationalTechnology Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 78. Medical InternationalTechnology NeedleFree Injectors Product Portfolios and Specifications
Table 79. Medical InternationalTechnology NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Medical InternationalTechnology Main Business
Table 81. Medical InternationalTechnology Latest Developments
Table 82. National Medical Products Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 83. National Medical Products NeedleFree Injectors Product Portfolios and Specifications
Table 84. National Medical Products NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. National Medical Products Main Business
Table 86. National Medical Products Latest Developments
Table 87. European Pharma Group Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 88. European Pharma Group NeedleFree Injectors Product Portfolios and Specifications
Table 89. European Pharma Group NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90. European Pharma Group Main Business
Table 91. European Pharma Group Latest Developments
Table 92. Valeritas Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 93. Valeritas NeedleFree Injectors Product Portfolios and Specifications
Table 94. Valeritas NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Valeritas Main Business
Table 96. Valeritas Latest Developments
Table 97. Endo International Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 98. Endo International NeedleFree Injectors Product Portfolios and Specifications
Table 99. Endo International NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Endo International Main Business
Table 101. Endo International Latest Developments
Table 102. Injex Pharma GmbH Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 103. Injex Pharma GmbH NeedleFree Injectors Product Portfolios and Specifications
Table 104. Injex Pharma GmbH NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 105. Injex Pharma GmbH Main Business
Table 106. Injex Pharma GmbH Latest Developments
Table 107. Bioject MedicalTechnologies Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 108. Bioject MedicalTechnologies NeedleFree Injectors Product Portfolios and Specifications
Table 109. Bioject MedicalTechnologies NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Bioject MedicalTechnologies Main Business
Table 111. Bioject MedicalTechnologies Latest Developments
Table 112. Antares Pharma Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 113. Antares Pharma NeedleFree Injectors Product Portfolios and Specifications
Table 114. Antares Pharma NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 115. Antares Pharma Main Business
Table 116. Antares Pharma Latest Developments
Table 117. European Pharma Group Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 118. European Pharma Group NeedleFree Injectors Product Portfolios and Specifications
Table 119. European Pharma Group NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 120. European Pharma Group Main Business
Table 121. European Pharma Group Latest Developments
Table 122. Wuhan ZJKCTechnology Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 123. Wuhan ZJKCTechnology NeedleFree Injectors Product Portfolios and Specifications
Table 124. Wuhan ZJKCTechnology NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 125. Wuhan ZJKCTechnology Main Business
Table 126. Wuhan ZJKCTechnology Latest Developments
Table 127. PenJet Corporation Basic Information, NeedleFree Injectors Manufacturing Base, Sales Area and Its Competitors
Table 128. PenJet Corporation NeedleFree Injectors Product Portfolios and Specifications
Table 129. PenJet Corporation NeedleFree Injectors Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 130. PenJet Corporation Main Business
Table 131. PenJet Corporation Latest Developments
LIST OFFIGURES
Figure 1. Picture of NeedleFree Injectors
Figure 2. NeedleFree Injectors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global NeedleFree Injectors Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global NeedleFree Injectors Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. NeedleFree Injectors Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. NeedleFree Injectors Sales Market Share by Country/Region (2024)
Figure 10. NeedleFree Injectors Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofFillable
Figure 12. Product Picture of Prefilled
Figure 13. Global NeedleFree Injectors Sales Market Share byType in 2025
Figure 14. Global NeedleFree Injectors Revenue Market Share byType (2020-2025)
Figure 15. NeedleFree Injectors Consumed in Hospitals
Figure 16. Global NeedleFree Injectors Market: Hospitals (2020-2025) & (K Units)
Figure 17. NeedleFree Injectors Consumed in Clinics
Figure 18. Global NeedleFree Injectors Market: Clinics (2020-2025) & (K Units)
Figure 19. NeedleFree Injectors Consumed in Other
Figure 20. Global NeedleFree Injectors Market: Other (2020-2025) & (K Units)
Figure 21. Global NeedleFree Injectors Sale Market Share by Application (2024)
Figure 22. Global NeedleFree Injectors Revenue Market Share by Application in 2025
Figure 23. NeedleFree Injectors Sales by Company in 2025 (K Units)
Figure 24. Global NeedleFree Injectors Sales Market Share by Company in 2025
Figure 25. NeedleFree Injectors Revenue by Company in 2025 ($ millions)
Figure 26. Global NeedleFree Injectors Revenue Market Share by Company in 2025
Figure 27. Global NeedleFree Injectors Sales Market Share by Geographic Region (2020-2025)
Figure 28. Global NeedleFree Injectors Revenue Market Share by Geographic Region in 2025
Figure 29. Americas NeedleFree Injectors Sales 2020-2025 (K Units)
Figure 30. Americas NeedleFree Injectors Revenue 2020-2025 ($ millions)
Figure 31. APAC NeedleFree Injectors Sales 2020-2025 (K Units)
Figure 32. APAC NeedleFree Injectors Revenue 2020-2025 ($ millions)
Figure 33. Europe NeedleFree Injectors Sales 2020-2025 (K Units)
Figure 34. Europe NeedleFree Injectors Revenue 2020-2025 ($ millions)
Figure 35. Middle East & Africa NeedleFree Injectors Sales 2020-2025 (K Units)
Figure 36. Middle East & Africa NeedleFree Injectors Revenue 2020-2025 ($ millions)
Figure 37. Americas NeedleFree Injectors Sales Market Share by Country in 2025
Figure 38. Americas NeedleFree Injectors Revenue Market Share by Country (2020-2025)
Figure 39. Americas NeedleFree Injectors Sales Market Share byType (2020-2025)
Figure 40. Americas NeedleFree Injectors Sales Market Share by Application (2020-2025)
Figure 41. United States NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 42. Canada NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 43. Mexico NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 44. Brazil NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 45. APAC NeedleFree Injectors Sales Market Share by Region in 2025
Figure 46. APAC NeedleFree Injectors Revenue Market Share by Region (2020-2025)
Figure 47. APAC NeedleFree Injectors Sales Market Share byType (2020-2025)
Figure 48. APAC NeedleFree Injectors Sales Market Share by Application (2020-2025)
Figure 49. China NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 50. Japan NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 51. South Korea NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 52. Southeast Asia NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 53. India NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 54. Australia NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 55. ChinaTaiwan NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 56. Europe NeedleFree Injectors Sales Market Share by Country in 2025
Figure 57. Europe NeedleFree Injectors Revenue Market Share by Country (2020-2025)
Figure 58. Europe NeedleFree Injectors Sales Market Share byType (2020-2025)
Figure 59. Europe NeedleFree Injectors Sales Market Share by Application (2020-2025)
Figure 60. Germany NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 61.France NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 62. UK NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 63. Italy NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 64. Russia NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 65. Middle East & Africa NeedleFree Injectors Sales Market Share by Country (2020-2025)
Figure 66. Middle East & Africa NeedleFree Injectors Sales Market Share byType (2020-2025)
Figure 67. Middle East & Africa NeedleFree Injectors Sales Market Share by Application (2020-2025)
Figure 68. Egypt NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 69. South Africa NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 70. Israel NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 71.Turkey NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 72. GCC Countries NeedleFree Injectors Revenue Growth 2020-2025 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of NeedleFree Injectors in 2025
Figure 74. Manufacturing Process Analysis of NeedleFree Injectors
Figure 75. Industry Chain Structure of NeedleFree Injectors
Figure 76. Channels of Distribution
Figure 77. Global NeedleFree Injectors Sales MarketForecast by Region (2026-2031)
Figure 78. Global NeedleFree Injectors Revenue Market ShareForecast by Region (2026-2031)
Figure 79. Global NeedleFree Injectors Sales Market ShareForecast byType (2026-2031)
Figure 80. Global NeedleFree Injectors Revenue Market ShareForecast byType (2026-2031)
Figure 81. Global NeedleFree Injectors Sales Market ShareForecast by Application (2026-2031)
Figure 82. Global NeedleFree Injectors Revenue Market ShareForecast by Application (2026-2031)
More Publications
Global Disposable Surgical Protective Gloves Market Growth 2024-2030
US$ 3,660.00
December 2024
147 pages
Global Operating Table Parts Market Growth 2024-2030
US$ 3,660.00
August 2024
157 pages
Global Swine Erysipelas Vaccine Market Growth 2023-2029
US$ 3,660.00
March 2023
101 pages
